Influence of Vitamin D and Cotinine on T-Regulatory Cells and Asthma Severity in Children
Asthma is a common chronic respiratory diseases in children. Understanding the immune mechanisms of epigenetic factors may contribute to a better control of asthma. This study seeks to determine the effects of serum vitamin D and urine cotinine on asthma severity and on T regulatory cells (Tregs) and other immune-related factors such as CD3, CD4, CD8, CD19, CD16/56, and anti-CD3 HLA-DR3. The study involved 34 children with asthma. Disease severity was assessed with the Asthma Control Test, spirometry, and the fractional exhaled nitric oxide (FeNO). The control group consisted of 18 healthy children. We found a significantly lower proportion of Tregs in the serum of asthmatic children compared with the control group (p < 0.002). There were no significant differences in the other immunological factors investigated. Nor was there any appreciable association between vitamin D or cotinine and the course of asthma, FeNO, Tregs, and the other immune factors. However, the percentage of Tregs was positively associated with the level of FeNO (p < 0.02). In conclusion, the study shows a role of T regulatory cells in the pathogenesis of asthma in children, but fails to show any influence of serum vitamin D or urine cotinine on disease course.
KeywordsAsthma Cotinine Exhaled nitric oxide Immune factors Regulatory T-cells Respiratory disease Spirometry Vitamin D
Conflicts of Interest
The authors declare no conflicts of interest in relation to this study.
- Brehm JM, Acosta-Pérez E, Klei L, Roeder K, Barmada M, Boutaoui N, Forno E, Kelly R, Paul K, Sylvia J, Litonjua AA, Cabana M, Alvarez M, Colon-Semidey A, Canino G, Celedon JC (2012) Vitamin D insufficiency and severe asthma exacerbations in Puerto Rican children. Am J Respir Crit Care Med 186(2):140146CrossRefGoogle Scholar
- Damera G, Fogle HW, Lim P, Goncharova EA, Zhao H, Banerjee A, Tliba O, Krymskaya VP, Panettieri RA (2009) Vitamin D inhibits growth of human airway smooth muscle cells through growth factor-induced phosphorylation of retinoblastoma protein and checkpoint kinase 1. J Pharmacol 158(6):1429–1441Google Scholar
- ECAP (2016) Epidemiology of allergic disorders in Poland. http://ecap.pl/eng_www/index_home.html; Accessed on 29 Dec 2016
- GINA (2014) From global strategy for asthma management and prevention. Updated December 2011. http://www.ginasthma.org/GINA-Report-Global-Strategy-for-AsthmaManagement-and-Prevention-Raport; Accessed on 29 Dec 2016
- GINA (2015) From the global strategy for asthma management and prevention, global initiative for asthma. http://www.ginasthma.org/; Accessed on 29 Dec 2016
- Halterman JS, Szilagyi PG, Yoos HL, Conn KM, Kaczorowski JM, Holzhauer RJ, Lauver SC, Neely TL, Callahan PM, McConnochie KM (2004) Benefits of a school-based asthma treatment program in the absence of secondhand smoke exposure: results of a randomized clinical trial. Arch Pediatr Adolesc Med 158(5):460–467CrossRefPubMedGoogle Scholar
- NAEPP (2007) Expert panel report 3: guidelines for the diagnosis and management of asthma. https://www.nhlbi.nih.gov/health-pro/resources/lung/naci/asthma-info/asthma-guidelines.htm; Accessed on 29 Dec 2016
- Pellegrino R et al. (2005) Interpretative strategies for lung function tests. Series ‘ATS/ERS Task force: standardisation of lung function testing’. V. Brusasco V, Crapo R, Viegi G (Eds). Eur Respir J 26:948–968Google Scholar
- Urry Z, Chambers ES, Xystrakis E, Dimeloe S, Richards DF, Gabryšová L, Christensen J, Gupta A, Saglani S, Bush A, O’Garra A, Brown Z, Hawrylowicz CM (2012) The role of 1α,25-dihydroxyvitamin D3 and cytokines in the promotion of distinct Foxp3+ and IL-10+ CD4+ T cells. Eur J Immunol 42(10):2697–2708CrossRefPubMedPubMedCentralGoogle Scholar
- Xystrakis E, Kusumakar S, Boswell S, Peek E, Urry Z, Richards DF, Adikibi T, Pridgeon C, Dallman M, Loke TK, Robinson DS, Barrat FJ, O’Garra A, Lavender P, Lee TH, Corrigan C, Hawrylowicz CM (2006) Reversing the defective induction of IL-10-secreting regulatory T cells in glucocorticoid-resistant asthma patients. J Clin Invest 116:146–155CrossRefPubMedGoogle Scholar